Dermot P McGovern MD PhD, FRCP, FACG, AGAF
Professor, Medicine, Cedars-Sinai Medical Center, Los Angeles
Join to View Full Profile
8700 Beverly BlvdWest Hollywood, CA 90048
Phone+1 310-423-4100
Fax+1 310-967-1800
Dr. McGovern is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of OxfordPhD, Complex Disease Genetics, 2000 - 2006
Imperial College London School of MedicineClass of 1993
Certifications & Licensure
CA State Medical License 2008 - 2024
Awards, Honors, & Recognition
- Membership American Association of Physicians, 2023
- Fellowship American Gastroenterology Association, 2023
- Fellowship American College of Gastroenterology, 2020
- Join now to see all
Clinical Trials
- Identification of Biomarkers of Janus Kinase Inhibitor Therapy in Patients With Ulcerative Colitis Start of enrollment: 2020 Aug 25
Publications & Presentations
PubMed
- 2 citationsAfter Surgically Induced Remission, Ileal and Colonic Mucosa-Associated Microbiota Predicts Crohn's Disease Recurrence.Cristian Hernández-Rocha, Williams Turpin, Krzysztof Borowski, Joanne M Stempak, Ksenija Sabic
Clinical Gastroenterology and Hepatology. 2025-03-01 - Eleven Grand Challenges for Inflammatory Bowel Disease Genetics and Genomics.Greg Gibson, John D Rioux, Judy H Cho, Talin Haritunians, Akshaya Thoutam
Inflammatory Bowel Diseases. 2025-01-06 - A Proteomics Pipeline for Generating Clinical Grade Biomarker Candidates from Data-Independent Acquisition Mass Spectrometry (DIA-MS) Discovery.Qin Fu, Manasa Vegesna, Niveda Sundararaman, Eugen Damoc, Tabiwang N Arrey
Angewandte Chemie. 2024-12-20
Press Mentions
Genetic Link to Severe UC IdentifiedFebruary 27th, 2025- Clinical Study Shows Efficacy of Monoclonal Antibody Treatment for Ulcerative ColitisSeptember 26th, 2024
- NEJM: Results from Targeted Therapy for Ulcerative Colitis StudySeptember 25th, 2024
- Join now to see all
Grant Support
- Understanding genetic architecture and host-microbiome interactions in Inflammatory bowel disease in under-represented minority populations and in patients with unmet medical need.CEDARS-SINAI MEDICAL CENTER2022–2027
Professional Memberships
- Fellow
- Fellow
- Royal College of Physicians (London)Fellow
Industry Relationships
- Founder, Prometheus Biosciences2018 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
